1. Home
  2. SWKS vs RDY Comparison

SWKS vs RDY Comparison

Compare SWKS & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skyworks Solutions Inc.

SWKS

Skyworks Solutions Inc.

HOLD

Current Price

$65.68

Market Cap

10.2B

Sector

Technology

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$12.16

Market Cap

9.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWKS
RDY
Founded
1962
1984
Country
United States
India
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
9.9B
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
SWKS
RDY
Price
$65.68
$12.16
Analyst Decision
Hold
Strong Buy
Analyst Count
15
1
Target Price
$70.38
$16.90
AVG Volume (30 Days)
4.7M
2.4M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
4.53%
0.52%
EPS Growth
N/A
N/A
EPS
0.99
N/A
Revenue
$4,086,900,000.00
N/A
Revenue This Year
N/A
$7.72
Revenue Next Year
$3.06
$3.50
P/E Ratio
$68.04
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$51.93
$11.36
52 Week High
$90.90
$15.67

Technical Indicators

Market Signals
Indicator
SWKS
RDY
Relative Strength Index (RSI) 48.97 45.35
Support Level $56.48 $12.19
Resistance Level $67.67 $12.58
Average True Range (ATR) 2.46 0.16
MACD -0.31 0.05
Stochastic Oscillator 40.82 33.90

Price Performance

Historical Comparison
SWKS
RDY

About SWKS Skyworks Solutions Inc.

Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: